26 results on '"Reed, Eddie"'
Search Results
2. Enhancing Response Rates in Physician Surveys: The Limited Utility of Electronic Options
3. Age does not influence taxol dose intensity in recurrent carcinoma of the ovary
4. Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age
5. Older women as the focus for research and treatment of ovarian cancer: An overview for the national institute on aging, national cancer institute, and American cancer society multidisciplinary working conference
6. Evaluation of Cisplatin in Combination with β-Elemene as a Regimen for Prostate Cancer Chemotherapy
7. Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer
8. Foreword: Promoting the use of registry-based national cancer surveillance data for colorectal cancer prevention and control
9. Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
10. Factors Involved in the Pharmacokinetics of COL‐3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer: Clinical and Experimental Studies
11. Phenylacetate Pharmacokinetics Based on Iterative Two-Stage Population Analysis
12. Reversible sideroblastic anemia associated with the tetracycline analogue COL-3
13. Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis
14. Meningeal Carcinomatosis in Metastatic Prostate Cancer: A Case Report
15. Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
16. A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
17. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma
18. PHARMACOKINETICS OF ELEMENTAL PLATINUM (ULTRAFILTRATE AND TOTAL) AFTER A THIRTY MINUTE INTRAVENOUS INFUSION OF ORMAPLATIN
19. Sensitization by interleukin-lα of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cellsin vitro andin vivo
20. Comparative analyses of relativeERCC3 andERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain
21. Closing Remarks
22. Severe thrombocytopenia in patients treated with suramin: Evidence for an immune mechanism in one
23. A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer
24. Acute renal toxicity associated with suramin in the treatment of prostate cancer
25. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay
26. Allopurinol kinetics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.